Physician profile
James M Doty
NPI 1891754230
$2,861.95
in general payments reported to CMS, 2019-2025
22 companies · $1,201 in 2025
The $1,201 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.35 · 2020: $728 · 2021: $146 · 2022: $246 · 2023: $260 · 2024: $188 · 2025: $1,201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,650.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $642.00 | 2020 | |
| Intuitive Surgical, INC. | $453.07 | 2022-2025 | Da Vinci Surgical System |
| Aroa Biosurgery Incorporated | $252.13 | 2025 | |
| Davol INC. | $193.42 | 2020-2024 | Phasix Mesh |
| Medtronic, INC. | $189.05 | 2021-2025 | Ligasure, Signia, Eea |
| Kerecis Limited | $187.50 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Integra Lifesciences Corporation | $154.41 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| W. L. Gore & Associates, INC. | $143.73 | 2025 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Vertex Pharmaceuticals Incorporated | $115.12 | 2025 | |
| Biotissue Holdings INC. | $100.23 | 2023 | |
| Covidien LP | $78.33 | 2019-2020 | |
| Conmed Corporation | $70.09 | 2022-2025 | Airseal, Conmed Handheld Instruments |
| Ethicon US, LLC | $60.40 | 2022-2025 | Echelon Flex |
| Reprise Biomedical, INC. | $39.30 | 2023 | Miro3d |
| Merck Sharp & Dohme LLC | $37.69 | 2019-2024 | Bridion |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $31.75 | 2021 | |
| Tela Bio, INC. | $25.75 | 2020 | |
| Bsn Medical INC | $22.15 | 2022 | |
| Innocoll Pharmaceuticals Limited | $18.78 | 2022 | |
| Shire North American Group INC | $18.41 | 2019 | |
| Allergan, INC. | $14.78 | 2020 | |
| International Rehabilitative Sciences, INC | $13.86 | 2023 | Rs 4i Plus Sequential Stimulator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Doty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.